These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 13848569)

  • 1. Alterations in Candida albicans during growth in the presence of amphotericin B.
    LONES GW; PEACOCK CL
    Antibiot Chemother (Northfield); 1959 Sep; 9():535-40. PubMed ID: 13848569
    [No Abstract]   [Full Text] [Related]  

  • 2. Activity of amphotericin B against Candida albicans. Disc sensitivity studies.
    CAMPBELL JB; SEGUIN L; KUTSCHER AH; ZEGARELLI EV
    Oral Surg Oral Med Oral Pathol; 1960 Oct; 13():1273-5. PubMed ID: 13690246
    [No Abstract]   [Full Text] [Related]  

  • 3. [Action of amphotericin B on the metabolism of some phosphorus compounds during growth in Candida albicans].
    HIRTH L; LEBEURIER G; DROUHET E
    C R Hebd Seances Acad Sci; 1959 Jun; 248(26):3733-5. PubMed ID: 13671786
    [No Abstract]   [Full Text] [Related]  

  • 4. In vitro response of Candida albicans and Candida tropicalis to antifungal agents.
    QUINN LY; WILBUR RD; CATRON DV
    Antibiot Chemother (Northfield); 1960 Feb; 10():95-100. PubMed ID: 14435571
    [No Abstract]   [Full Text] [Related]  

  • 5. [Mechanism of action of antifungal antibiotics. I. Action of amphotericin B on the respiratory metabolism of Candida albicans].
    DROUHET E; HIRTH L; LEBEURIER G
    Ann Inst Pasteur (Paris); 1960 Apr; 98():469-84. PubMed ID: 13818193
    [No Abstract]   [Full Text] [Related]  

  • 6. A comparison of triacetin and nystatin with respect to their stability and effect on Candida albicans.
    KUBISTA RA; DERSE PH
    Antibiot Chemother (Northfield); 1959 Sep; 9():546-9. PubMed ID: 14412413
    [No Abstract]   [Full Text] [Related]  

  • 7. Development of strains of Candida albicans resistant to candidin.
    HEBEKA EK; SOLOTOROVSKY M
    J Bacteriol; 1962 Aug; 84(2):237-41. PubMed ID: 13905811
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of various drugs on the growth of Candida albicans during antibiotic therapy, including amphotericin, a new antifungal antibiotic.
    CHILDS AJ
    Scott Med J; 1957 Oct; 2(10):400-2. PubMed ID: 13486086
    [No Abstract]   [Full Text] [Related]  

  • 9. ["CANDIDA ALBICANS" MENINGITIS IN AN INFANT TREATED BY AMPHOTERICIN B. RECOVERY].
    VERGER P; GUILLARD JM; BOISSEAU M
    Arch Fr Pediatr; 1964 May; 21():569-78. PubMed ID: 14158917
    [No Abstract]   [Full Text] [Related]  

  • 10. [Mycostatic activity in vitro of hystatin, trichomycin and dichlorohydroxyquinaldine].
    SARACENI G
    Boll Ist Sieroter Milan; 1959; 38():342-6. PubMed ID: 14441694
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of the antifungal agent X-5079C on the growth of Histoplasma capsulatum in vitro.
    LONES GW; PEACOCK CL
    Am Rev Respir Dis; 1961 Oct; 84():529-33. PubMed ID: 13763314
    [No Abstract]   [Full Text] [Related]  

  • 12. EFFECT OF NYSTATIN AND AMPHOTERICIN B ON THE GROWTH OF CANDIDA ALBICANS.
    GHOSH A; GHOSH JJ
    Ann Biochem Exp Med; 1963 Jan; 23():29-44. PubMed ID: 14060842
    [No Abstract]   [Full Text] [Related]  

  • 13. Antifungal activity of amphotericin B and voriconazole against the biofilms and biofilm-dispersed cells of Candida albicans employing a newly developed in vitro pharmacokinetic model.
    El-Azizi M; Farag N; Khardori N
    Ann Clin Microbiol Antimicrob; 2015 Apr; 14():21. PubMed ID: 25885806
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Experimental animal studies with antimycotic substances. Part 2. Comparative studies on the effectiveness of peroral and subcutaneous application of amphotericin B on an experimental model of mice infected with Candida albicans, Cryptococcus neoformans, Mucor pusillus or Aspergillus fumigatus].
    OSSWALD H; SEELIGER HP
    Z Immun exp ther; 1960 Feb; 119():161-74. PubMed ID: 14429266
    [No Abstract]   [Full Text] [Related]  

  • 15. An evaluation of amphotericin B in vitro and in vivo in mice against Coccidioides immitis and Candida albicans, and preliminary observations concerning the administration of amphotericin B to man.
    HALDE C; NEWCOMER VD; WRIGHT ET; STERNBERG TH
    J Invest Dermatol; 1957 Mar; 28(3):217-31; discussion, 231-2. PubMed ID: 13429161
    [No Abstract]   [Full Text] [Related]  

  • 16. In vitro activity of antifungal combinations against Candida albicans biofilms.
    Tobudic S; Kratzer C; Lassnigg A; Graninger W; Presterl E
    J Antimicrob Chemother; 2010 Feb; 65(2):271-4. PubMed ID: 19996142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Repurposing as a means to increase the activity of amphotericin B and caspofungin against Candida albicans biofilms.
    Delattin N; De Brucker K; Vandamme K; Meert E; Marchand A; Chaltin P; Cammue BP; Thevissen K
    J Antimicrob Chemother; 2014 Apr; 69(4):1035-44. PubMed ID: 24284780
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The efficiency of the benzothiazole APB, the echinocandin micafungin, and amphotericin B in fluconazole-resistant Candida albicans and Candida dubliniensis.
    Melkusová S; Bujdáková H; Volleková A; Myoken Y; Mikami Y
    Pharmazie; 2004 Jul; 59(7):573-4. PubMed ID: 15296100
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in some Candida albicans virulence factors due to amphotericin-B post-antifungal effect.
    Ozkutuk A; Dogan Y; Kirdar S; Ozkutuk N
    J Chemother; 2007 Feb; 19(1):101-3. PubMed ID: 17309860
    [No Abstract]   [Full Text] [Related]  

  • 20. Multiple effects of green tea catechin on the antifungal activity of antimycotics against Candida albicans.
    Hirasawa M; Takada K
    J Antimicrob Chemother; 2004 Feb; 53(2):225-9. PubMed ID: 14688042
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.